Nesina

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 64764-625
  • Package NDC 64764-625-30
  • Package NDC 64764-625-90
  • Application number NDA022271
  • SPL ID 225103de-a3f2-47ee-bebb-4aa24b16aab4
  • SPL set ID a3768c7e-aa4c-44d3-bc53-43bb7346c0b0
  • UNII EEN99869SC
  • RxCUI 1368006
  • RxCUI 1368012
  • RxCUI 1368018
  • RxCUI 1368020
  • RxCUI 1368034
  • RxCUI 1368036

What the source publishes

Labeler
Takeda Pharmaceuticals America, Inc.
Active ingredients
alogliptin
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:64764-625_225103de-a3f2-47ee-bebb-4aa24b16aab4
{
  "name": "Nesina",
  "splId": "225103de-a3f2-47ee-bebb-4aa24b16aab4",
  "labels": [
    {
      "setId": "a3768c7e-aa4c-44d3-bc53-43bb7346c0b0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a3768c7e-aa4c-44d3-bc53-43bb7346c0b0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Takeda Pharmaceuticals America, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET, FILM COATED in 1 BOTTLE (64764-625-30)",
      "package_ndc": "64764-625-30",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130125"
    },
    {
      "sample": false,
      "description": "90 TABLET, FILM COATED in 1 BOTTLE (64764-625-90)",
      "package_ndc": "64764-625-90",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20130125"
    }
  ],
  "productId": "64764-625_225103de-a3f2-47ee-bebb-4aa24b16aab4",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "64764-625",
  "deaSchedule": null,
  "genericName": "alogliptin",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ALOGLIPTIN BENZOATE",
      "strength": "6.25 mg/1"
    }
  ],
  "applicationNumber": "NDA022271",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20130125",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0364764125301",
      "0364764625306",
      "0364764250300"
    ],
    "unii": [
      "EEN99869SC"
    ],
    "rxcui": [
      "1368006",
      "1368012",
      "1368018",
      "1368020",
      "1368034",
      "1368036"
    ],
    "spl_set_id": [
      "a3768c7e-aa4c-44d3-bc53-43bb7346c0b0"
    ],
    "manufacturer_name": [
      "Takeda Pharmaceuticals America, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:64764-625_225103de-a3f2-47ee-bebb-4aa24b16aab4"